Other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct (DrugBank: 18F-FDG)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 84 | サルコイドーシス | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01764191 (ClinicalTrials.gov) | January 2013 | 3/1/2013 | 18F-FDG PET Imaging in Cardiac Sarcoidosis | [18 F]-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography (PET) in Cardiac Sarcoidosis | Cardiac Sarcoidosis | Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT | British Columbia Cancer Agency | NULL | Approved for marketing | 19 Years | N/A | All | Canada |